Sign in
4

Changes in Ownership

Rani Therapeutics Holdings, Inc. Filed Acc 0001209191-22-021022

Chief Executive Officer acquired 86,600 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Imran Talat Chief Executive Officer 2022-03-22 Grant or award +86,600 98,943 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Imran Talat Chief Executive Officer 2022-03-22 Grant or award · Stock Option (Right to Buy) +263,400 263,400 D: show line 2 in the form
Loading xslF345X03/doc4.xml…